Research Article

Development and Validation of a TNF Family-Based Signature for Predicting Prognosis, Tumor Immune Characteristics, and Immunotherapy Response in Colorectal Cancer Patients

Figure 3

Validation of the eight-gene TNF family-based signature (TFS) for CRC patients using GEO data. (a) Heatmap of the mRNA expression of the eight genes in the TFS, survival status, and TFS risk scores in the high- and low-risk groups. The Kaplan–Meier survival analyses of the patients in the high- and low-risk groups in the (b) meta-GEO cohort (), and in the (c) GSE17536 (), (d) GSE39582 (), (e) GSE17537 (), and (f) GSE87211 () datasets.
(a)
(b)
(c)
(d)
(e)
(f)